Overexpression of Hypoxia Inducible Factor-1 Alpha is an Independent Risk Factor for Recurrence After Curative Resection of Colorectal Liver Metastases

HIF1A Overexpression Is Associated with Poor Prognosis in a Cohort of 731 Colorectal Cancers

(2010) Yoshifumi Baba et al.   AMERICAN JOURNAL OF PATHOLOGY

Prognostic Significance of c-erbB-2 and Vascular Endothelial Growth Factor in Colorectal Liver Metastases

(2010) Jinggui Chen et al.   ANNALS OF SURGICAL ONCOLOGY

Clinicopathological significance of nuclear factor-kappa B, HIF-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer

(2010) Hyuk-Chan Kwon et al.   CANCER SCIENCE

Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications

(2009) Dan Cao et al.   BMC CANCER

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

(2009) S Rasheed et al.   BRITISH JOURNAL OF CANCER

Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-Inducible Factor-1  and -2  in Colon Cancer

(2009) H. Kikuchi et al.   CANCER RESEARCH

PTEN Expression and KRAS Mutations on Primary Tumors and Metastases in the Prediction of Benefit From Cetuximab Plus Irinotecan for Patients With Metastatic Colorectal Cancer

(2009) Fotios Loupakis et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Basis of Colorectal Cancer

(2009) Sanford D. Markowitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

(2009) G L Semenza   ONCOGENE

Patterns of Recurrence Following Liver Resection for Colorectal Metastases

(2008) Lia Assumpcao   ARCHIVES OF SURGERY

Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression

(2008) Nektaria Simiantonaki et al.   BMC CANCER

HIF-1α and HIF-2α have divergent roles in colon cancer

(2008) Takaaki Imamura et al.   INTERNATIONAL JOURNAL OF CANCER

Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity

(2008) R. Sullivan et al.   MOLECULAR CANCER THERAPEUTICS